Literature DB >> 29809169

ATP11B mediates platinum resistance in ovarian cancer.

Myrthala Moreno-Smith, J B Halder, Paul S Meltzer, Tamas A Gonda, Lingegowda S Mangala, Rajesha Rupaimoole, Chunhua Lu, Archana S Nagaraja, Kshipra M Gharpure, Yu Kang, Cristian Rodriguez-Aguayo, Pablo E Vivas-Mejia, Behrouz Zand, Rosemarie Schmandt, Hua Wang, Robert R Langley, Nicholas B Jennings, Cristina Ivan, Jeremy E Coffin, Guillermo N Armaiz, Justin Bottsford-Miller, Sang Bae Kim, Margaret S Halleck, Mary Jc Hendrix, William Bornman, Menashe Bar-Eli, Ju-Seog Lee, Zahid H Siddik, Gabriel Lopez-Berestein, Anil K Sood.   

Abstract

Entities:  

Year:  2018        PMID： 29809169      PMCID： PMC6025990          DOI： 10.1172/JCI122301

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  Identification of Key Genes and Pathway for Ovarian Neoplasms Using the OVDM1 Cell Line Based on Bioinformatics Analysis.

Authors:  Songna Yin; Juan Du; Jie Zhang; Xiang Zhang; Ke Ma
Journal:  Med Sci Monit       Date:  2019-06-09

2.  Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer.

Authors:  Ricardo Noriega-Rivera; Mariela Rivera-Serrano; Robert J Rabelo-Fernandez; Josué Pérez-Santiago; Fatima Valiyeva; Pablo E Vivas-Mejía
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

3.  RUNDC3A regulates SNAP25-mediated chemotherapy resistance by binding AKT in gastric neuroendocrine carcinoma (GNEC).

Authors:  Pengchen Chen; Wei Wang; Sin Wa Wong; Junnan Li; Qiushaung Wu; Shu-Dong Zhang; Yao Lin; Hang Fai Kwok
Journal:  Cell Death Discov       Date:  2022-06-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.